Quantcast

Novus Medical Detox Conquers Florida Business Journals’ Fast 100

September 30, 2013

Novus Medical Detox is one of Florida’s fastest growing companies—the detox facility earned number 92 on the 2013 Florida Fast 100 Awards List.

New Port Richey, FL (PRWEB) September 30, 2013

Novus Medical Detox, one of the only Florida-based detox centers servicing high-dosage prescription drug abuse patients across the U.S., attended the Florida Business Journals’ 2013 Florida’s Fast 100 Awards Dinner on September 26 at the Gaylord Palms Resort & Convention Center in Orlando, FL. Novus was honored as one of the 100 fastest growing and privately held companies in Florida, ranking number 92 on the list.

As part of the Florida Fast 100, Novus was one of several Tampa Bay businesses that upheld the list’s stringent criteria: Novus is privately held, owned and headquartered in Florida; the company also showed tremendous growth between 2010 and 2012; and it provided documentation verifying its revenue figures (2).

Novus has maintained steady company growth in what some deem a competitive economy, largely due to the effectiveness of its medical detox protocol:

●    Novus opened its doors with the purpose of overhauling the detox process to ensure that anyone could overcome prescription drug addiction comfortably and with dignity;

●    Unlike many other detox programs, Novus pays particular attention to strengthening its patients’ bodies through a proprietary I.V. vitamin cocktail that is tailored to make the detox process as painless as possible and replenishes nutrients lost during drug abuse; and

●    The vitamin I.V. is an advanced medical finding that has allowed Novus to handle the toughest of drug and alcohol cases—cases that are rejected from other facilities as “too high a risk.”

Novus Executive Director, Kent Runyon, says that detox is not only a critical step in recovering from addiction, but it is often the hardest—Runyon feels that the Florida Fast 100 award is a testament to the success of Novus’ programs and processes.

“As a facility that strives to uphold top-notch standards of medical care, being recognized in any capacity is always an honor—[Novus] staff works diligently to ensure that our patients remain comfortable as possible in a trusted, safe environment,” said Runyon. “Our main goal is the health of our patients, and being recognized is an encouragement.”

Novus says that the face of detox has changed—they now primarily service professionals and their family members who have become addicted to prescription pain medications unwittingly after an injury or surgery.

“The prescription drug epidemic is sadly affecting our brightest and most contributing members of society,” Runyon added.

Novus also recently received accreditation from The Joint Commission, and ranked number 4436 on Inc. Magazine’s 500/5000 list of fastest-growing companies. Novus was one of 38 Tampa Bay businesses to be featured on the Florida Fast 100 list.

For more information about Novus Medical Detox and its detox and rehabilitation programs, visit http://www.novusdetox.com.

About Novus Medical Detox:

Novus Medical Detox Center offers safe, effective alcohol and drug treatment programs in a home-like residential setting. Located on 3.25 tree-lined acres in New Port Richey, Fla., Novus is Joint Commission accredited and licensed by the Florida Department of Children and Families as an in-patient medical detox facility. Novus is known for minimizing the discomfort of withdrawal from prescription medication, drugs and alcohol by creating a customized detox program for each patient, incorporating medication, natural supplements and fluid replenishment—putting dignity and humanity back into drug detoxification. Patients have 24/7 medical supervision, including round-the-clock nursing care and access to a withdrawal specialist, and enjoy comfortable private or shared rooms with a telephone, television, DVD player and high-speed Internet access. For more information on Novus Medical Detox Center, visit http://www.novusdetox.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/9/prweb11176008.htm


Source: prweb



comments powered by Disqus